{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:08:04Z","timestamp":1769108884426,"version":"3.49.0"},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,10,29]],"date-time":"2003-10-29T00:00:00Z","timestamp":1067385600000},"content-version":"vor","delay-in-days":2553,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1996,11]]},"abstract":"<jats:p> <jats:bold>OBJECTIVES\u2003Sleep apnoea is common in active acromegaly. It is associated with increased morbidity and mortality but can be treated effectively. The objective of this study was to determine the largely unknown relative frequency of, and the predictive factors for, sleep apnoea in treated acromegalic patients.<\/jats:bold> <\/jats:p><jats:p> <jats:bold>DESIGN\u2003Retrospective cohort study.<\/jats:bold> <\/jats:p><jats:p> <jats:bold>SETTING\u2003Tertiary referral hospital.<\/jats:bold> <\/jats:p><jats:p> <jats:bold>PATIENTS\u2003Fifty\u2010four of 100 patients with treated acromegaly. If sleep apnoea had been diagnosed before acromegaly, the patient was excluded.<\/jats:bold> <\/jats:p><jats:p> <jats:bold>MEASUREMENTS\u2003Sleep studies (using the MESAM\u20104 device measuring oxyhaemoglobin saturation, heart rate, snoring sounds and body position to determine presence and severity of sleep apnoea); GH and IGF\u2010I levels; body mass index, neck and index\u2010finger circumference; daytime symptoms of sleep apnoea, duration of acromegaly before treatment, shoe and neck\u2010size difference since beginning of acromegaly; age, sex and treatment modes of acromegaly.<\/jats:bold> <\/jats:p><jats:p> <jats:bold>RESULTS\u2003The relative frequency of sleep apnoea was 39% in the 54 patients with sleep studies and at least 21% in the entire study population of 100 patients.<\/jats:bold> <\/jats:p><jats:p> <jats:bold>In patients with sleep apnoea, statistically significant higher values were observed for GH (<jats:italic>P<\/jats:italic>\u2003=\u20030.002), IGF\u2010I (<jats:italic>P<\/jats:italic>\u2003=\u20030.029), age (<jats:italic>P<\/jats:italic>\u2003=\u20030.014) and neck circumference (<jats:italic>P<\/jats:italic>\u2003=\u20030.016). An index\u2010finger circumference of \u22658.5\u2003cm was associated with a significantly higher desaturation index (<jats:italic>P<\/jats:italic>\u2003=\u20030.012, Mann\u2013Whitney <jats:italic>I<\/jats:italic>test). Adenomectomy had been performed significantly less frequently in patients with sleep apnoea (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001, \u03c7<jats:sup>2<\/jats:sup> test). The body mass index was non\u2010significantly higher in the patients with sleep apnoea.<\/jats:bold> <\/jats:p><jats:p> <jats:bold>CONCLUSIONS\u2003The relative frequency of sleep apnoea in patients with treated acromegaly is at least 21%. Parameters of predictive value for the presence of sleep apnoea in this population are neck and index\u2010finger circumference as measures of soft tissue hypertrophy, age, GH and IGF\u2010I levels, and whether or not operative therapy was applied.<\/jats:bold> <\/jats:p>","DOI":"10.1046\/j.1365-2265.1996.00852.x","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T16:07:17Z","timestamp":1068134837000},"page":"563-569","source":"Crossref","is-referenced-by-count":69,"title":["<b>Sleep apnoea in treated acromegaly: relative frequency and predisposing factors<\/b>"],"prefix":"10.1111","volume":"45","author":[{"given":"Felix","family":"Rosenow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Deu\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Szelies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf\u2010Dieter","family":"Hilgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf\u2010Dieter","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,29]]},"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1996.00852.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1996.00852.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1996.00852.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:29:32Z","timestamp":1698402572000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1996.00852.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["10.1046\/j.1365-2265.1996.00852.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1996.00852.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}